InvestorLens

APLS — APELLIS PHARMACEUTICALS INC

Public company

Sign in to save0 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Tracked investors currently reporting APLS

6 tracked investors have since exited this position — listed separately below.

  • No tracked investors hold this ticker.

Previously held APLS

These investors reported APLS in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Steve CohenPoint72 Asset Management4.2M$168.3MMar 31, 2026
Izzy EnglanderMillennium Management2.3M$91.1MMar 31, 2026
George SorosSoros Fund Management1.1M$42.5MMar 31, 2026
Ken GriffinCitadel Advisors263.3K$10.6MMar 31, 2026
Ray DalioBridgewater Associates34.9K$1.4MMar 31, 2026
Paul Tudor JonesTudor Investment Corp49.1K$1.1MSep 30, 2025

Recent activity